TABLE 3.
Amino acid-derived variables during the acute infusion trial1
| WP supplement (n = 11) | CP supplement (n = 11) | P | |
|---|---|---|---|
| ΣTotal amino acids | |||
| Cmax, μM | 10,041 ± 4793 | 8808 ± 5276 | 0.15 |
| Tmax, min | 64 ± 31 | 84 ± 37 | 0.10 |
| AUC, μmol · min/L | 1,431,600 ± 10,900 | 1,205,300± 16,900 | >0.05 |
| ΣEAAs | |||
| Cmax, μM | 5733 ± 2368 | 2869 ± 1604 | 0.003 |
| Tmax, min | 50 ± 10 | 46 ± 13 | 0.23 |
| AUC, μmol · min/L | 775,000 ± 12,800 | 442,900 ± 10,800 | 0.003 |
| Leucine | |||
| Cmax, μM | 645 ± 206 | 223 ± 117 | <0.001 |
| Tmax, min | 54 ± 9 | 62 ± 31 | 0.22 |
| AUC, μmol · min/L | 103,800 ± 17,700 | 43,600 ± 10,100 | 0.012 |
1Values are means ± SDs. AUC was calculated over the 240 min after study beverage ingestion. Analysis by nonpaired t test. Cmax, maximum concentration; CP, collagen peptide; EAA, essential amino acid; Tmax, time of maximum concentration; WP, whey protein; Σ, sum of.